Levamisole is an antihelminthic drug that was commonly used for the treatment of parasitic, viral, and bacterial infections. It was manufactured by Janssen and first used in 1969 as an agent to treat worm infestations Levamisole was approved by the FDA in 1990 as an adjuvant treatment for colon cancer. Prior to this, levamisole was used as an antirheumatic ...
For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.
Children's Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Anhui Children's Hospital, Hefei, Anhui, China
Children's Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Blood Diseases Hospital Chinese Academy of Medical Sciences, TianJin, Tianjin, China
Azadegan Street,Imam Hospital,Department of Dermatology, Ahvaz, Khoozestan, Iran, Islamic Republic of
Faghihi Hospital Hemodialysis Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
Helminth Control Laboratory Unguja, Stone Town, Tanzania
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.